These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 17413871)

  • 21. Inhibition of CD8+ T lymphocytes attenuates respiratory syncytial virus-enhanced allergic inflammation.
    Jiang XB; Wang ZD; Zhu Y; Zhang XL; Cui XF; Yao K; Yin KS
    Respiration; 2009; 77(1):76-84. PubMed ID: 18818487
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Timing of infection and prior immunization with respiratory syncytial virus (RSV) in RSV-enhanced allergic inflammation.
    Barends M; Van Oosten M; De Rond CG; Dormans JA; Osterhaus AD; Neijens HJ; Kimman TG
    J Infect Dis; 2004 May; 189(10):1866-72. PubMed ID: 15122523
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficient lung recruitment of respiratory syncytial virus-specific Th1 cells induced by recombinant bacillus Calmette-Guérin promotes virus clearance and protects from infection.
    Cautivo KM; Bueno SM; Cortes CM; Wozniak A; Riedel CA; Kalergis AM
    J Immunol; 2010 Dec; 185(12):7633-45. PubMed ID: 21084664
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Respiratory syncytial virus-induced airway hyperresponsiveness is independent of IL-13 compared with that induced by allergen.
    Park JW; Taube C; Yang ES; Joetham A; Balhorn A; Takeda K; Miyahara N; Dakhama A; Donaldson DD; Gelfand EW
    J Allergy Clin Immunol; 2003 Dec; 112(6):1078-87. PubMed ID: 14657862
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contribution of neuroimmune mechanisms to airway inflammation and remodeling during and after respiratory syncytial virus infection.
    Piedimonte G
    Pediatr Infect Dis J; 2003 Feb; 22(2 Suppl):S66-74; discussion S74-5. PubMed ID: 12671455
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alleviation of respiratory syncytial virus replication and inflammation by fungal immunomodulatory protein FIP-fve from Flammulina velutipes.
    Chang YC; Chow YH; Sun HL; Liu YF; Lee YT; Lue KH; Ko JL
    Antiviral Res; 2014 Oct; 110():124-31. PubMed ID: 25131377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Respiratory syncytial virus-induced exaggeration of allergic airway disease is dependent upon CCR1-associated immune responses.
    John AE; Gerard CJ; Schaller M; Miller AL; Berlin AA; Humbles AA; Lukacs NW
    Eur J Immunol; 2005 Jan; 35(1):108-16. PubMed ID: 15593301
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Persistence of airway hyperresponsiveness and viral antigen following respiratory syncytial virus bronchiolitis in young guinea-pigs.
    Riedel F; Oberdieck B; Streckert HJ; Philippou S; Krusat T; Marek W
    Eur Respir J; 1997 Mar; 10(3):639-45. PubMed ID: 9072998
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Respiratory syncytial virus enhances respiratory allergy in mice despite the inhibitory effect of virus-induced interferon-gamma.
    Barends M; Boelen A; de Rond L; Dormans J; Kwakkel J; van Oosten M; Neijens HJ; Kimman TG
    J Med Virol; 2003 Jan; 69(1):156-62. PubMed ID: 12436492
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peripheral blood mononuclear cells from infants hospitalized because of respiratory syncytial virus infection express T helper-1 and T helper-2 cytokines and CC chemokine messenger RNA.
    Tripp RA; Moore D; Barskey A; Jones L; Moscatiello C; Keyserling H; Anderson LJ
    J Infect Dis; 2002 May; 185(10):1388-94. PubMed ID: 11992272
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Critical role of IFN-alpha/beta and IFN-gamma in the regulation of airway inflammation].
    Ashino S; Nishimura T
    Nihon Rinsho; 2006 Jul; 64(7):1260-8. PubMed ID: 16838642
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IL-5 and eosinophils are essential for the development of airway hyperresponsiveness following acute respiratory syncytial virus infection.
    Schwarze J; Cieslewicz G; Hamelmann E; Joetham A; Shultz LD; Lamers MC; Gelfand EW
    J Immunol; 1999 Mar; 162(5):2997-3004. PubMed ID: 10072551
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Respiratory syncytial virus infection of airway epithelial cells, in vivo and in vitro, supports pulmonary antibody responses by inducing expression of the B cell differentiation factor BAFF.
    McNamara PS; Fonceca AM; Howarth D; Correia JB; Slupsky JR; Trinick RE; Al Turaiki W; Smyth RL; Flanagan BF
    Thorax; 2013 Jan; 68(1):76-81. PubMed ID: 23002173
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Respiratory syncytial virus infection enhances airway hyperresponsiveness in guinea pigs and the underlined mechanism].
    Fang LP; Qi HW; Lin HJ; Li SJ; Xu DL
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2009 Feb; 25(1):121-4. PubMed ID: 21186634
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of mite allergen-pulsed murine dendritic cells by respiratory syncytial virus.
    Kondo Y; Matsuse H; Machida I; Kawano T; Saeki S; Tomari S; Obase Y; Fukushima C; Kohno S
    Am J Respir Crit Care Med; 2004 Feb; 169(4):494-8. PubMed ID: 14656751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An immunocompromised BALB/c mouse model for respiratory syncytial virus infection.
    Kong X; Hellermann GR; Patton G; Kumar M; Behera A; Randall TS; Zhang J; Lockey RF; Mohapatra SS
    Virol J; 2005 Feb; 2():3. PubMed ID: 15701174
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Respiratory syncytial virus-induced acute and chronic airway disease is independent of genetic background: an experimental murine model.
    Chávez-Bueno S; Mejías A; Gómez AM; Olsen KD; Ríos AM; Fonseca-Aten M; Ramilo O; Jafri HS
    Virol J; 2005 May; 2():46. PubMed ID: 15916706
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune and functional role of nitric oxide in a mouse model of respiratory syncytial virus infection.
    Stark JM; Khan AM; Chiappetta CL; Xue H; Alcorn JL; Colasurdo GN
    J Infect Dis; 2005 Feb; 191(3):387-95. PubMed ID: 15633098
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of mucosal and systemic immunity against respiratory syncytial virus by inactivated virus supplemented with TLR9 and NOD2 ligands.
    Shafique M; Wilschut J; de Haan A
    Vaccine; 2012 Jan; 30(3):597-606. PubMed ID: 22120195
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pulmonary peptidergic innervation remodeling and development of airway hyperresponsiveness induced by RSV persistent infection.
    Tan YR; Yang T; Liu SP; Xiang Y; Qu F; Liu HJ; Qin XQ
    Peptides; 2008 Jan; 29(1):47-56. PubMed ID: 18055066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.